# Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD

> **NCT03831880** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 87 (actual)

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **DRUG:** Genotropin
- **DRUG:** somatrogon

## Key facts

- **NCT ID:** NCT03831880
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-07
- **Primary completion:** 2020-08-28
- **Final completion:** 2020-08-28
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2021-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03831880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03831880, "Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03831880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*